Tirzepatide

tirzepatide

dual incretin agonist

Tirzepatide is a dual GIP/GLP-1 receptor agonist with one of the strongest modern evidence bases in obesity and diabetes medicine.

fat-loss|metabolism|diabetes

It activates both GIP and GLP-1 pathways to improve glycemic control, suppress appetite, reduce caloric intake, and meaningfully lower body weight.

Approved Drug Level | FDA Approved

advanced-metabolic-stack|metabolic-stack

fat-loss|metabolism|diabetes|cardiometabolic

semaglutide-vs-tirzepatide|retatrutide-vs-tirzepatide

/images/tirzepatide.jpg

published

‹ Thymosin Alpha-1

MK-677 ›